| # | Drug | Count |
|---|---|---|
| 0 | IBUPROFEN | 29 |
| 1 | ACETAMINOPHEN | 28 |
| 2 | ALPRAZOLAM | 28 |
| 3 | IBUPFROFEN | 28 |
| 4 | IBUPROFEN 200 MG | 28 |
| 5 | IBUPROFEN 200MG | 28 |
| 6 | IBUPROFEN CAPSULE | 28 |
| 7 | IBUPROFEN CAPSULES 200 MG | 28 |
| 8 | IBUPROFEN ORAL | 28 |
| 9 | IBUPROFEN TABLET, FILM COATED | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMISULPRIDE | 19 | 0.0031 |
| 1 | METEX | 1 | 0.0026 |
| 2 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 3 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 4 | BODY CLEANSER | 1 | 0.0014 |
| 5 | CLOBAZAM | 20 | 0.0011 |
| 6 | TRANDOLAPRIL TABLETS | 2 | 0.0010 |
| 7 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 8 | OXAZEPAM | 18 | 0.0008 |
| 9 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 54 |
| 1 | Corticosteroid [EPC] | 39 |
| 2 | Benzodiazepine [EPC] | 33 |
| 3 | Opioid Agonist [EPC] | 31 |
| 4 | GLP-1 Receptor Agonist [EPC] | 28 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 20 |
| 6 | Insulin Analog [EPC] | 19 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 20 | 0.0026 |
| 1 | Hedgehog Pathway Inhibitor [EPC] | 6 | 0.0006 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Opioid Agonist [EPC] | 31 | 0.0001 |